Georgia vs Singapore: The number of people with susceptibility test result for rifampicin
Georgia
99.79
in 2021
Singapore
98.69
in 2021
Georgia rank
33rd
Singapore rank
35th
The number of people with susceptibility test result for rifampicin over time
- Georgia
- Singapore
How they compare
Georgia currently reports 99.79 against 98.69 in Singapore, a difference of 1.1.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Georgia ahead.
Georgia ranks 33rd and Singapore ranks 35th of 146 countries.
Georgia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Georgia | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 98.27 | 97.43 | 0.84 | Georgia |
| 2020s | 99.8 | 98.42 | 1.38 | Georgia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Georgia or Singapore?
- Georgia, at 99.79 against 98.69 in Singapore as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Georgia and Singapore?
- 1.1, with Georgia ahead.
- How many years of comparable data are there for Georgia and Singapore?
- 5 years are reported by both, from 2017 to 2021.
- How do Georgia and Singapore rank globally for the number of people with susceptibility test result for rifampicin?
- Georgia ranks 33rd and Singapore ranks 35th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.